Liraglutide and Dulaglutide therapy in addition to SGLT-2 inhibitor and metformin treatment in Indian type 2 diabetics: a real world retrospective observational study

Liraglutide and Dulaglutide therapy in addition to SGLT-2 inhibitor and metformin treatment in Indian type 2 diabetics: a real world retrospective observational study

Abstract Background Therapy for Type 2 diabetes (T2D) has been transformed by the introduction of newer agents like Glucagon like Peptide Receptor Agonists (GLP-1RA) and Sodium-glucose linked transporter inhibitors (SGLT2i). However with co-initiation of SGLT2i and GLP-1RA in the DURATION 8 trial an...

Full description

Bibliographic Details
Main Authors: S. Ghosal, B. Sinha
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Clinical Diabetes and Endocrinology
Subjects:
Diabetes
Liraglutide
Dulaglutide
SGLT-2i
HbA1c
Weight
Online Access:http://link.springer.com/article/10.1186/s40842-018-0061-8

Internet

http://link.springer.com/article/10.1186/s40842-018-0061-8

Similar Items